Treatment of Advanced Non-Small Cell Luna Cancer in 2018

被引:88
作者
Doroshow, Deborah B. [1 ]
Herbst, Roy S. [1 ]
机构
[1] Yale Canc Ctr, 333 Cedar St,POB 208028, New Haven, CT 06520 USA
关键词
PHASE-III; PEMBROLIZUMAB; CHEMOTHERAPY; OSIMERTINIB; CARBOPLATIN;
D O I
10.1001/jamaoncol.2017.5190
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:569 / 570
页数:2
相关论文
共 50 条
  • [31] Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer
    Takeda, Koji
    Daga, Haruko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1541 - 1547
  • [32] Maintenance Therapy in Advanced Non-small Cell Lung Cancer
    Coate, Linda E.
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 723 - 734
  • [33] The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer
    Sakin, A.
    Sahin, S.
    Atci, M. M.
    Sakin, A.
    Yasar, N.
    Geredeli, C.
    Aksaray, F.
    Cihan, S.
    PULMONOLOGY, 2021, 27 (01): : 26 - 34
  • [34] Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer
    Neal, Joel W.
    ONCOLOGIST, 2010, 15 (01) : 3 - 5
  • [35] Salvage treatment with anlotinib for advanced non-small cell lung cancer
    Wu, Di
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Han, Jindi
    Han, Sen
    Long, Jieran
    Wang, Yang
    Zhang, Ziran
    Fang, Jian
    THORACIC CANCER, 2019, 10 (07) : 1590 - 1596
  • [36] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2016, 11 (06) : 825 - 835
  • [37] Systemic therapy of elderly patients with advanced non-small cell lung cancer-individualized treatment is key
    Pirker, Robert
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [38] SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
    M. Majem
    O. Juan
    A. Insa
    N. Reguart
    J. M. Trigo
    E. Carcereny
    R. García-Campelo
    Y. García
    M. Guirado
    M. Provencio
    Clinical and Translational Oncology, 2019, 21 : 3 - 17
  • [39] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [40] SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
    Majem, M.
    Juan, O.
    Insa, A.
    Reguart, N.
    Trigo, J. M.
    Carcereny, E.
    Garcia-Campelo, R.
    Garcia, Y.
    Guirado, M.
    Provencio, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (01) : 3 - 17